Bessemer Group Inc Johnson & Johnson Transaction History

Bessemer Group Inc

$56.7 Billion
Q2 2024

A detailed history of Bessemer Group Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Bessemer Group Inc holds 753,873 shares of JNJ stock, worth $125 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

753,873

Previous 783,238 3.75%

Holding current value

$125 Million

Previous $124 Million 11.07%

% of portfolio

0.19%

Previous 0.22%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$144.38 - $157.78 $4.24 Million - $4.63 Million	-29,365 Reduced 3.75%	753,873 $110 Million
Q1 2024 May 13, 2024	BUY	$155.22 - $162.74 $5.17 Million - $5.42 Million	33,301 Added 4.44%	783,238 $124 Million
Q4 2023 Feb 09, 2024	SELL	$145.6 - $158.88 $13.3 Million - $14.6 Million	-91,612 Reduced 10.89%	749,937 $118 Million
Q3 2023 Nov 13, 2023	BUY	$155.75 - $174.48 $26.7 Million - $29.9 Million	171,382 Added 25.57%	841,549 $131 Million
Q2 2023 Aug 10, 2023	BUY	$154.35 - $166.11 $64.3 Million - $69.2 Million	416,596 Added 164.29%	670,167 $111 Million
Q1 2023 May 10, 2023	SELL	$151.05 - $180.26 $1.52 Million - $1.81 Million	-10,031 Reduced 3.81%	253,571 $39.3 Million
Q4 2022 Feb 13, 2023	SELL	$160.2 - $179.79 $1.48 Million - $1.66 Million	-9,219 Reduced 3.38%	263,602 $46.6 Million
Q3 2022 Nov 09, 2022	SELL	$161.33 - $179.52 $338,793 - $376,992	-2,100 Reduced 0.76%	272,821 $44.6 Million
Q2 2022 Aug 10, 2022	SELL	$168.19 - $186.01 $4.75 Million - $5.26 Million	-28,268 Reduced 9.32%	274,921 $48.8 Million
Q1 2022 May 12, 2022	SELL	$158.14 - $179.59 $8.52 Million - $9.68 Million	-53,896 Reduced 15.09%	303,189 $53.7 Million
Q4 2021 Jan 27, 2022	BUY	$155.93 - $173.01 $11.6 Million - $12.8 Million	74,251 Added 26.25%	357,085 $61.1 Million
Q3 2021 Nov 12, 2021	BUY	$161.5 - $179.47 $10.1 Million - $11.3 Million	62,785 Added 28.53%	282,834 $45.7 Million
Q2 2021 Aug 06, 2021	BUY	$159.48 - $171.07 $710,961 - $762,630	4,458 Added 2.07%	220,049 $36.3 Million
Q1 2021 May 13, 2021	BUY	$153.07 - $170.48 $1.36 Million - $1.52 Million	8,904 Added 4.31%	215,591 $35.4 Million
Q4 2020 Feb 09, 2021	SELL	$137.11 - $157.38 $5.92 Million - $6.79 Million	-43,144 Reduced 17.27%	206,687 $32.5 Million
Q3 2020 Nov 12, 2020	SELL	$140.38 - $153.83 $2.63 Million - $2.88 Million	-18,746 Reduced 6.98%	249,831 $37.2 Million
Q2 2020 Aug 05, 2020	BUY	$128.81 - $155.51 $3.23 Million - $3.9 Million	25,097 Added 10.31%	268,577 $37.8 Million
Q1 2020 Apr 30, 2020	BUY	$111.14 - $153.99 $5.46 Million - $7.56 Million	49,097 Added 25.26%	243,480 $31.9 Million
Q4 2019 Feb 04, 2020	BUY	$127.5 - $146.44 $1.71 Million - $1.96 Million	13,397 Added 7.4%	194,383 $28.4 Million
Q3 2019 Nov 07, 2019	BUY	$126.95 - $142.14 $1.49 Million - $1.67 Million	11,715 Added 6.92%	180,986 $23.4 Million
Q2 2019 Jul 19, 2019	SELL	$131.15 - $144.24 $1.04 Million - $1.15 Million	-7,955 Reduced 4.49%	169,271 $23.6 Million
Q1 2019 May 13, 2019	SELL	$125.72 - $139.79 $3.41 Million - $3.79 Million	-27,100 Reduced 13.26%	177,226 $24.8 Million
Q4 2018 Feb 12, 2019	SELL	$122.84 - $147.84 $187 Million - $225 Million	-1,523,346 Reduced 88.17%	204,326 $26.4 Million
Q3 2018 Nov 06, 2018	SELL	$121.58 - $142.88 $33.8 Million - $39.7 Million	-277,676 Reduced 13.85%	1,727,672 $239 Million
Q2 2018 Jul 25, 2018	BUY	$119.4 - $131.76 $16.5 Million - $18.2 Million	138,051 Added 7.39%	2,005,348 $243 Million
Q1 2018 May 10, 2018	BUY	$125.1 - $148.14 $6.54 Million - $7.74 Million	52,265 Added 2.88%	1,867,297 $239 Million
Q4 2017 Jan 30, 2018	SELL	$131.22 - $143.62 $8.97 Million - $9.82 Million	-68,365 Reduced 3.63%	1,815,032 $254 Million
Q3 2017 Nov 03, 2017	BUY	$129.47 - $135.38 $244 Million - $255 Million	1,883,397	1,883,397 $245 Million

Others Institutions Holding JNJ

# of Institutions

4,161

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $434B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.

Account

Bessemer Group Inc Johnson & Johnson Transaction History